pmc-enju-pas Home  

PMC:3312845 / 26894-28469 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T10561 0-5 NN denotes MIP-2
T10562 6-16 NN denotes expression
T10563 17-22 NN denotes MIP-2
T10564 23-25 VB denotes is
T10565 26-27 DT denotes a
T10566 28-36 JJ denotes powerful
T10567 37-46 NN denotes chemokine
T10568 47-51 WDT denotes that
T10569 52-63 VB denotes contributes
T10570 64-66 TO denotes to
T10571 67-78 NN denotes recruitment
T10572 79-81 IN denotes of
T10573 82-93 NN denotes neutrophils
T10574 94-95 -LRB- denotes [
T10575 95-97 CD denotes 27
T10576 97-98 -RRB- denotes ]
T10577 100-105 NN denotes MIP-2
T10578 106-108 VB denotes is
T10579 109-121 JJ denotes undetectable
T10580 122-124 CC denotes or
T10581 125-132 JJ denotes present
T10582 133-135 IN denotes at
T10583 136-139 JJ denotes low
T10584 140-146 NN denotes levels
T10585 147-152 IN denotes under
T10586 153-166 JJ denotes physiological
T10587 167-177 NN denotes conditions
T10588 177-178 -COMMA- denotes ,
T10589 179-182 CC denotes and
T10590 183-188 VB denotes shows
T10591 189-198 JJ denotes transient
T10592 199-208 NN denotes increases
T10593 209-214 IN denotes under
T10594 215-227 JJ denotes pathological
T10595 228-238 NN denotes conditions
T10596 239-242 IN denotes via
T10597 243-248 NN denotes TNF-α
T10598 249-255 CC denotes and/or
T10599 256-270 NN denotes interleukin-1β
T10600 271-272 -LRB- denotes (
T10601 272-277 NN denotes IL-1β
T10602 277-278 -RRB- denotes )
T10603 278-288 JJ denotes -dependent
T10604 289-299 NN denotes mechanisms
T10605 300-301 -LRB- denotes [
T10606 301-303 CD denotes 14
T10607 303-304 -RRB- denotes ]
T10608 306-310 RB denotes Thus
T10609 310-311 -COMMA- denotes ,
T10610 312-314 PRP denotes it
T10611 315-320 MD denotes would
T10612 321-323 VB denotes be
T10613 324-333 JJ denotes plausible
T10614 334-338 IN denotes that
T10615 339-353 JJ denotes TNF-α-mediated
T10616 354-359 NN denotes MIP-2
T10617 360-370 NN denotes expression
T10618 371-374 MD denotes may
T10619 375-382 VB denotes provoke
T10620 383-393 JJ denotes SE-induced
T10621 394-404 NN denotes neutrophil
T10622 405-418 NN denotes infiltrations
T10623 420-422 TO denotes To
T10624 423-430 VB denotes confirm
T10625 431-435 DT denotes this
T10626 436-446 NN denotes hypothesis
T10627 446-447 -COMMA- denotes ,
T10628 448-450 PRP denotes we
T10629 451-463 VB denotes investigated
T10630 464-469 NN denotes MIP-2
T10631 470-480 NN denotes expression
T10632 481-483 IN denotes in
T10633 484-487 DT denotes the
T10634 488-490 NN denotes PC
T10635 492-502 JJ denotes Consistent
T10636 503-507 IN denotes with
T10637 508-511 PRP-DOLLAR- denotes our
T10638 512-520 JJ denotes previous
T10639 521-526 NN denotes study
T10640 527-528 -LRB- denotes [
T10641 528-530 CD denotes 20
T10642 530-531 -RRB- denotes ]
T10643 531-532 -COMMA- denotes ,
T10644 533-537 DT denotes some
T10645 538-552 JJ denotes MIP-2-positive
T10646 553-563 NN denotes astrocytes
T10647 564-568 VB denotes were
T10648 569-577 VB denotes observed
T10649 578-580 IN denotes in
T10650 581-584 DT denotes the
T10651 585-589 NN denotes core
T10652 590-593 CC denotes and
T10653 594-603 NN denotes periphery
T10654 604-606 IN denotes of
T10655 607-610 DT denotes the
T10656 611-620 JJ denotes vasogenic
T10657 621-626 NN denotes edema
T10658 627-634 NN denotes lesions
T10659 634-635 -COMMA- denotes ,
T10660 636-639 CC denotes but
T10661 640-643 RB denotes not
T10662 644-646 IN denotes in
T10663 647-650 DT denotes the
T10664 651-664 JJ denotes non-vasogenic
T10665 665-670 NN denotes edema
T10666 671-677 NN denotes region
T10667 678-679 -LRB- denotes (
T10668 679-685 NN denotes Figure
T10669 686-688 NN denotes 6B
T10670 689-692 CC denotes and
T10671 693-695 NN denotes 6C
T10672 695-696 -RRB- denotes )
T10673 698-706 IN denotes Although
T10674 707-710 DT denotes the
T10675 711-717 NN denotes number
T10676 718-720 IN denotes of
T10677 721-726 NN denotes MIP-2
T10678 727-735 JJ denotes positive
T10679 736-741 NN denotes cells
T10680 742-745 IN denotes per
T10681 746-750 NN denotes unit
T10682 751-755 NN denotes area
T10683 756-758 IN denotes in
T10684 759-762 DT denotes the
T10685 763-765 NN denotes PC
T10686 766-772 NN denotes region
T10687 773-775 IN denotes of
T10688 776-792 JJ denotes sTNFp55R-infused
T10689 793-800 NN denotes animals
T10690 801-804 VB denotes was
T10691 805-818 RB denotes significantly
T10692 819-824 JJ denotes lower
T10693 825-829 IN denotes than
T10694 830-834 DT denotes that
T10695 835-837 IN denotes of
T10696 838-841 DT denotes the
T10697 842-856 JJ denotes saline-infused
T10698 857-862 NN denotes group
T10699 863-866 JJ denotes due
T10700 867-869 TO denotes to
T10701 870-879 NN denotes reduction
T10702 880-882 IN denotes of
T10703 883-886 DT denotes the
T10704 887-891 NN denotes area
T10705 892-894 IN denotes of
T10706 895-904 JJ denotes vasogenic
T10707 905-910 NN denotes edema
T10708 910-911 -COMMA- denotes ,
T10709 912-917 EX denotes there
T10710 918-921 VB denotes was
T10711 922-924 DT denotes no
T10712 925-935 NN denotes difference
T10713 936-938 IN denotes in
T10714 939-942 DT denotes the
T10715 943-949 NN denotes number
T10716 950-952 IN denotes of
T10717 953-958 NN denotes MIP-2
T10718 959-967 JJ denotes positive
T10719 968-973 NN denotes cells
T10720 974-977 IN denotes per
T10721 978-982 NN denotes unit
T10722 983-987 NN denotes area
T10723 988-990 IN denotes of
T10724 991-1000 JJ denotes vasogenic
T10725 1001-1006 NN denotes edema
T10726 1007-1014 IN denotes between
T10727 1015-1031 JJ denotes sTNFp55R-infused
T10728 1032-1039 NN denotes animals
T10729 1040-1043 CC denotes and
T10730 1044-1058 JJ denotes saline-infused
T10731 1059-1066 NN denotes animals
T10732 1067-1068 -LRB- denotes (
T10733 1068-1074 NN denotes Figure
T10734 1075-1077 NN denotes 6F
T10735 1077-1078 -RRB- denotes )
T10736 1080-1091 RB denotes Furthermore
T10737 1091-1092 -COMMA- denotes ,
T10738 1093-1096 DT denotes the
T10739 1097-1103 NN denotes number
T10740 1104-1106 IN denotes of
T10741 1107-1121 JJ denotes MIP-2-positive
T10742 1122-1127 NN denotes cells
T10743 1128-1134 VB denotes showed
T10744 1135-1136 DT denotes a
T10745 1137-1143 JJ denotes direct
T10746 1144-1154 NN denotes proportion
T10747 1155-1157 TO denotes to
T10748 1158-1161 DT denotes the
T10749 1162-1166 NN denotes unit
T10750 1167-1171 NN denotes area
T10751 1172-1174 IN denotes of
T10752 1175-1184 JJ denotes vasogenic
T10753 1185-1190 NN denotes edema
T10754 1191-1195 IN denotes with
T10755 1196-1197 DT denotes a
T10756 1198-1204 JJ denotes linear
T10757 1205-1216 NN denotes coefficient
T10758 1217-1219 IN denotes of
T10759 1220-1231 NN denotes correlation
T10760 1232-1234 IN denotes of
T10761 1235-1240 CD denotes 0.682
T10762 1241-1242 -LRB- denotes (
T10763 1242-1243 NN denotes p
T10764 1244-1245 SYM denotes <
T10765 1246-1250 CD denotes 0.05
T10766 1250-1251 -COMMA- denotes ,
T10767 1252-1258 NNP denotes Figure
T10768 1259-1261 NN denotes 6G
T10769 1261-1262 -RRB- denotes )
T10770 1264-1273 RB denotes Therefore
T10771 1273-1274 -COMMA- denotes ,
T10772 1275-1283 RB denotes together
T10773 1284-1288 IN denotes with
T10774 1289-1298 NN denotes reduction
T10775 1299-1301 IN denotes in
T10776 1302-1312 NN denotes neutrophil
T10777 1313-1325 NN denotes infiltration
T10778 1326-1328 IN denotes in
T10779 1329-1332 DT denotes the
T10780 1333-1335 NN denotes PC
T10781 1336-1342 NN denotes region
T10782 1343-1345 IN denotes of
T10783 1346-1362 JJ denotes sTNFp55R-infused
T10784 1363-1370 NN denotes animals
T10785 1370-1371 -COMMA- denotes ,
T10786 1372-1375 PRP-DOLLAR- denotes our
T10787 1376-1384 NN denotes findings
T10788 1385-1392 VB denotes provide
T10789 1393-1401 NN denotes evidence
T10790 1402-1406 IN denotes that
T10791 1407-1412 NN denotes TNF-α
T10792 1413-1416 MD denotes may
T10793 1417-1425 VB denotes regulate
T10794 1426-1436 JJ denotes SE-induced
T10795 1437-1447 NN denotes neutrophil
T10796 1448-1460 NN denotes infiltration
T10797 1461-1463 IN denotes at
T10798 1464-1469 JJ denotes least
T10799 1470-1472 IN denotes in
T10800 1473-1476 DT denotes the
T10801 1477-1479 NN denotes PC
T10802 1480-1483 IN denotes via
T10803 1484-1493 JJ denotes vasogenic
T10804 1494-1499 NN denotes edema
T10805 1500-1509 NN denotes formation
T10806 1510-1513 CC denotes and
T10807 1514-1517 RB denotes not
T10808 1518-1521 IN denotes via
T10809 1522-1528 JJ denotes direct
T10810 1529-1543 JJ denotes TNF-α-mediated
T10811 1544-1549 NN denotes MIP-2
T10812 1550-1560 NN denotes expression
T10813 1561-1563 IN denotes in
T10814 1564-1574 NN denotes astrocytes
R8447 T10562 T10561 arg1Of expression,MIP-2
R8448 T10563 T10564 arg1Of MIP-2,is
R8449 T10567 T10564 arg2Of chemokine,is
R8450 T10567 T10565 arg1Of chemokine,a
R8451 T10567 T10566 arg1Of chemokine,powerful
R8452 T10567 T10568 arg1Of chemokine,that
R8453 T10567 T10569 arg1Of chemokine,contributes
R8454 T10569 T10570 arg1Of contributes,to
R8455 T10571 T10570 arg2Of recruitment,to
R8456 T10571 T10572 arg1Of recruitment,of
R8457 T10573 T10572 arg2Of neutrophils,of
R8458 T10573 T10574 arg1Of neutrophils,[
R8459 T10575 T10574 arg2Of 27,[
R8460 T10576 T10574 arg3Of ],[
R8461 T10577 T10578 arg1Of MIP-2,is
R8462 T10577 T10579 arg1Of MIP-2,undetectable
R8463 T10577 T10581 arg1Of MIP-2,present
R8464 T10577 T10590 arg1Of MIP-2,shows
R8465 T10578 T10589 arg1Of is,and
R8466 T10579 T10580 arg1Of undetectable,or
R8467 T10580 T10578 arg2Of or,is
R8468 T10580 T10582 arg1Of or,at
R8469 T10581 T10580 arg2Of present,or
R8470 T10584 T10582 arg2Of levels,at
R8471 T10584 T10583 arg1Of levels,low
R8472 T10584 T10585 arg1Of levels,under
R8473 T10587 T10585 arg2Of conditions,under
R8474 T10587 T10586 arg1Of conditions,physiological
R8475 T10589 T10588 arg1Of and,","
R8476 T10590 T10589 arg2Of shows,and
R8477 T10590 T10593 arg1Of shows,under
R8478 T10590 T10596 arg1Of shows,via
R8479 T10592 T10590 arg2Of increases,shows
R8480 T10592 T10591 arg1Of increases,transient
R8481 T10595 T10593 arg2Of conditions,under
R8482 T10595 T10594 arg1Of conditions,pathological
R8483 T10597 T10598 arg1Of TNF-α,and/or
R8484 T10598 T10596 arg2Of and/or,via
R8485 T10601 T10600 arg2Of IL-1β,(
R8486 T10602 T10600 arg3Of ),(
R8487 T10604 T10598 arg2Of mechanisms,and/or
R8488 T10604 T10599 arg1Of mechanisms,interleukin-1β
R8489 T10604 T10600 arg1Of mechanisms,(
R8490 T10604 T10603 arg1Of mechanisms,-dependent
R8491 T10604 T10605 arg1Of mechanisms,[
R8492 T10606 T10605 arg2Of 14,[
R8493 T10607 T10605 arg3Of ],[
R8494 T10612 T10608 arg1Of be,Thus
R8495 T10612 T10609 arg1Of be,","
R8496 T10612 T10611 arg2Of be,would
R8497 T10613 T10612 arg2Of plausible,be
R8498 T10617 T10615 arg1Of expression,TNF-α-mediated
R8499 T10617 T10616 arg1Of expression,MIP-2
R8500 T10617 T10618 arg1Of expression,may
R8501 T10617 T10619 arg1Of expression,provoke
R8502 T10619 T10610 arg1Of provoke,it
R8503 T10619 T10611 arg1Of provoke,would
R8504 T10619 T10612 arg1Of provoke,be
R8505 T10619 T10613 arg1Of provoke,plausible
R8506 T10619 T10614 arg1Of provoke,that
R8507 T10619 T10618 arg2Of provoke,may
R8508 T10622 T10619 arg2Of infiltrations,provoke
R8509 T10622 T10620 arg1Of infiltrations,SE-induced
R8510 T10622 T10621 arg1Of infiltrations,neutrophil
R8511 T10624 T10623 arg1Of confirm,To
R8512 T10626 T10624 arg2Of hypothesis,confirm
R8513 T10626 T10625 arg1Of hypothesis,this
R8514 T10628 T10624 arg1Of we,confirm
R8515 T10628 T10629 arg1Of we,investigated
R8516 T10629 T10623 modOf investigated,To
R8517 T10629 T10627 arg1Of investigated,","
R8518 T10631 T10629 arg2Of expression,investigated
R8519 T10631 T10630 arg1Of expression,MIP-2
R8520 T10631 T10632 arg1Of expression,in
R8521 T10634 T10632 arg2Of PC,in
R8522 T10634 T10633 arg1Of PC,the
R8523 T10635 T10636 arg1Of Consistent,with
R8524 T10639 T10636 arg2Of study,with
R8525 T10639 T10637 arg1Of study,our
R8526 T10639 T10638 arg1Of study,previous
R8527 T10639 T10640 arg1Of study,[
R8528 T10641 T10640 arg2Of 20,[
R8529 T10642 T10640 arg3Of ],[
R8530 T10646 T10635 arg1Of astrocytes,Consistent
R8531 T10646 T10644 arg1Of astrocytes,some
R8532 T10646 T10645 arg1Of astrocytes,MIP-2-positive
R8533 T10646 T10647 arg1Of astrocytes,were
R8534 T10646 T10648 arg2Of astrocytes,observed
R8535 T10648 T10635 modOf observed,Consistent
R8536 T10648 T10643 arg1Of observed,","
R8537 T10648 T10647 arg2Of observed,were
R8538 T10648 T10649 arg1Of observed,in
R8539 T10648 T10662 arg1Of observed,in
R8540 T10649 T10660 arg1Of in,but
R8541 T10651 T10652 arg1Of core,and
R8542 T10652 T10649 arg2Of and,in
R8543 T10652 T10650 arg1Of and,the
R8544 T10652 T10654 arg1Of and,of
R8545 T10653 T10652 arg2Of periphery,and
R8546 T10658 T10654 arg2Of lesions,of
R8547 T10658 T10655 arg1Of lesions,the
R8548 T10658 T10656 arg1Of lesions,vasogenic
R8549 T10658 T10657 arg1Of lesions,edema
R8550 T10660 T10659 arg1Of but,","
R8551 T10662 T10660 arg2Of in,but
R8552 T10662 T10661 arg1Of in,not
R8553 T10666 T10662 arg2Of region,in
R8554 T10666 T10663 arg1Of region,the
R8555 T10666 T10664 arg1Of region,non-vasogenic
R8556 T10666 T10665 arg1Of region,edema
R8557 T10666 T10667 arg1Of region,(
R8558 T10669 T10668 arg1Of 6B,Figure
R8559 T10669 T10670 arg1Of 6B,and
R8560 T10670 T10667 arg2Of and,(
R8561 T10671 T10670 arg2Of 6C,and
R8562 T10672 T10667 arg3Of ),(
R8563 T10675 T10674 arg1Of number,the
R8564 T10675 T10676 arg1Of number,of
R8565 T10675 T10690 arg1Of number,was
R8566 T10675 T10692 arg1Of number,lower
R8567 T10679 T10676 arg2Of cells,of
R8568 T10679 T10677 arg1Of cells,MIP-2
R8569 T10679 T10678 arg1Of cells,positive
R8570 T10679 T10680 arg1Of cells,per
R8571 T10682 T10680 arg2Of area,per
R8572 T10682 T10681 arg1Of area,unit
R8573 T10682 T10683 arg1Of area,in
R8574 T10686 T10683 arg2Of region,in
R8575 T10686 T10684 arg1Of region,the
R8576 T10686 T10685 arg1Of region,PC
R8577 T10686 T10687 arg1Of region,of
R8578 T10689 T10687 arg2Of animals,of
R8579 T10689 T10688 arg1Of animals,sTNFp55R-infused
R8580 T10690 T10673 arg2Of was,Although
R8581 T10692 T10690 arg2Of lower,was
R8582 T10692 T10691 arg1Of lower,significantly
R8583 T10692 T10693 arg1Of lower,than
R8584 T10692 T10700 arg1Of lower,to
R8585 T10694 T10693 arg2Of that,than
R8586 T10694 T10695 arg1Of that,of
R8587 T10698 T10695 arg2Of group,of
R8588 T10698 T10696 arg1Of group,the
R8589 T10698 T10697 arg1Of group,saline-infused
R8590 T10698 T10699 arg1Of group,due
R8591 T10701 T10700 arg2Of reduction,to
R8592 T10701 T10702 arg1Of reduction,of
R8593 T10704 T10702 arg2Of area,of
R8594 T10704 T10703 arg1Of area,the
R8595 T10704 T10705 arg1Of area,of
R8596 T10707 T10705 arg2Of edema,of
R8597 T10707 T10706 arg1Of edema,vasogenic
R8598 T10709 T10710 arg1Of there,was
R8599 T10710 T10673 arg1Of was,Although
R8600 T10710 T10708 arg1Of was,","
R8601 T10712 T10710 arg2Of difference,was
R8602 T10712 T10711 arg1Of difference,no
R8603 T10712 T10713 arg1Of difference,in
R8604 T10712 T10720 arg1Of difference,per
R8605 T10715 T10713 arg2Of number,in
R8606 T10715 T10714 arg1Of number,the
R8607 T10715 T10716 arg1Of number,of
R8608 T10719 T10716 arg2Of cells,of
R8609 T10719 T10717 arg1Of cells,MIP-2
R8610 T10719 T10718 arg1Of cells,positive
R8611 T10722 T10720 arg2Of area,per
R8612 T10722 T10721 arg1Of area,unit
R8613 T10722 T10723 arg1Of area,of
R8614 T10725 T10723 arg2Of edema,of
R8615 T10725 T10724 arg1Of edema,vasogenic
R8616 T10725 T10726 arg1Of edema,between
R8617 T10728 T10727 arg1Of animals,sTNFp55R-infused
R8618 T10728 T10729 arg1Of animals,and
R8619 T10729 T10726 arg2Of and,between
R8620 T10731 T10729 arg2Of animals,and
R8621 T10731 T10730 arg1Of animals,saline-infused
R8622 T10731 T10732 arg1Of animals,(
R8623 T10734 T10732 arg2Of 6F,(
R8624 T10734 T10733 arg1Of 6F,Figure
R8625 T10735 T10732 arg3Of ),(
R8626 T10739 T10738 arg1Of number,the
R8627 T10739 T10740 arg1Of number,of
R8628 T10739 T10743 arg1Of number,showed
R8629 T10742 T10740 arg2Of cells,of
R8630 T10742 T10741 arg1Of cells,MIP-2-positive
R8631 T10743 T10736 arg1Of showed,Furthermore
R8632 T10743 T10737 arg1Of showed,","
R8633 T10746 T10743 arg2Of proportion,showed
R8634 T10746 T10744 arg1Of proportion,a
R8635 T10746 T10745 arg1Of proportion,direct
R8636 T10746 T10747 arg1Of proportion,to
R8637 T10750 T10747 arg2Of area,to
R8638 T10750 T10748 arg1Of area,the
R8639 T10750 T10749 arg1Of area,unit
R8640 T10750 T10751 arg1Of area,of
R8641 T10750 T10754 arg1Of area,with
R8642 T10753 T10751 arg2Of edema,of
R8643 T10753 T10752 arg1Of edema,vasogenic
R8644 T10757 T10754 arg2Of coefficient,with
R8645 T10757 T10755 arg1Of coefficient,a
R8646 T10757 T10756 arg1Of coefficient,linear
R8647 T10757 T10758 arg1Of coefficient,of
R8648 T10759 T10758 arg2Of correlation,of
R8649 T10759 T10760 arg1Of correlation,of
R8650 T10761 T10760 arg2Of 0.682,of
R8651 T10761 T10762 arg1Of 0.682,(
R8652 T10763 T10762 arg2Of p,(
R8653 T10763 T10764 arg1Of p,<
R8654 T10763 T10765 arg1Of p,0.05
R8655 T10763 T10766 arg1Of p,","
R8656 T10768 T10766 arg2Of 6G,","
R8657 T10768 T10767 arg1Of 6G,Figure
R8658 T10769 T10762 arg3Of ),(
R8659 T10773 T10772 arg1Of with,together
R8660 T10774 T10773 arg2Of reduction,with
R8661 T10774 T10775 arg1Of reduction,in
R8662 T10777 T10775 arg2Of infiltration,in
R8663 T10777 T10776 arg1Of infiltration,neutrophil
R8664 T10777 T10778 arg1Of infiltration,in
R8665 T10781 T10778 arg2Of region,in
R8666 T10781 T10779 arg1Of region,the
R8667 T10781 T10780 arg1Of region,PC
R8668 T10781 T10782 arg1Of region,of
R8669 T10784 T10782 arg2Of animals,of
R8670 T10784 T10783 arg1Of animals,sTNFp55R-infused
R8671 T10787 T10786 arg1Of findings,our
R8672 T10787 T10788 arg1Of findings,provide
R8673 T10788 T10770 arg1Of provide,Therefore
R8674 T10788 T10771 arg1Of provide,","
R8675 T10788 T10773 arg1Of provide,with
R8676 T10788 T10785 arg1Of provide,","
R8677 T10789 T10788 arg2Of evidence,provide
R8678 T10791 T10792 arg1Of TNF-α,may
R8679 T10791 T10793 arg1Of TNF-α,regulate
R8680 T10793 T10789 arg2Of regulate,evidence
R8681 T10793 T10790 arg1Of regulate,that
R8682 T10793 T10792 arg2Of regulate,may
R8683 T10793 T10799 arg1Of regulate,in
R8684 T10793 T10808 arg1Of regulate,via
R8685 T10796 T10793 arg2Of infiltration,regulate
R8686 T10796 T10794 arg1Of infiltration,SE-induced
R8687 T10796 T10795 arg1Of infiltration,neutrophil
R8688 T10798 T10797 arg1Of least,at
R8689 T10799 T10798 arg1Of in,least
R8690 T10799 T10806 arg1Of in,and
R8691 T10801 T10799 arg2Of PC,in
R8692 T10801 T10800 arg1Of PC,the
R8693 T10801 T10802 arg1Of PC,via
R8694 T10805 T10802 arg2Of formation,via
R8695 T10805 T10803 arg1Of formation,vasogenic
R8696 T10805 T10804 arg1Of formation,edema
R8697 T10808 T10806 arg2Of via,and
R8698 T10808 T10807 arg1Of via,not
R8699 T10812 T10808 arg2Of expression,via
R8700 T10812 T10809 arg1Of expression,direct
R8701 T10812 T10810 arg1Of expression,TNF-α-mediated
R8702 T10812 T10811 arg1Of expression,MIP-2
R8703 T10812 T10813 arg1Of expression,in
R8704 T10814 T10813 arg2Of astrocytes,in